Atlas Trials

Pharmacokinetic and Efficacy Profile Intranasal Scopolamine Spray

Clinical trial NCT02155309 · TERMINATED

Trial details

NCT number
NCT02155309
Sponsor
Repurposed Therapeutics, Inc.
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Motion Sickness
Start date
2014-06-01
Primary completion
2016-03-01
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.